Ubiquitination/ Proteasome
Once the substrate protein is labeled, proteasome will bind to a polyubiquitin chain, allowing the degradation of the labeled protein. The polyubiquitinated target protein is then recognized and degraded by the 26S proteasome. Deubiquitinating enzymes (DUBs) reverse the process of ubiquitination by removing ubiquitin from its substrate protein. Dysregulation of the ubiquitin-proteasome system has been linked to cancer, diabetes, cardiovascular and neurodegenerative diseases etc.
- B6032 CB-5083Target: p97Summary: p97 inhibitor
- A2324 Dexamethasone (DHAP)Target: interleukin receptorSummary: Glucocorticoidan; anti-inflammatory
- A4083 Rocilinostat (ACY-1215)1 CitationTarget: Histone Deacetylases (HDACs)Summary: Selective HDAC6 inhibitor
- A4010 Salinosporamide A (NPI-0052, Marizomib)Target: ProteasomeSummary: 20S proteasome inhibitor
- A2614 Bortezomib (PS-341)24 CitationTarget: ProteasomeSummary: Proteasome Inhibitor
- A1933 Carfilzomib (PR-171)10 CitationTarget: ProteasomeSummary: Proteasome inhibitor, epoxomicin analog